GoHealth, Inc. (GOCO)
NASDAQ: GOCO · Real-Time Price · USD
3.030
+0.090 (3.06%)
Dec 5, 2025, 4:00 PM EST - Market closed
GoHealth Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2018 |
| Revenue | 738.34 | 798.89 | 734.67 | 631.68 | 1,062 | 877.35 | Upgrade
|
| Revenue Growth (YoY) | 7.56% | 8.74% | 16.30% | -40.54% | 21.09% | 62.62% | Upgrade
|
| Cost of Revenue | 144.01 | 130.61 | 158.96 | 187.67 | 239.34 | 199.2 | Upgrade
|
| Gross Profit | 594.33 | 668.28 | 575.71 | 444.01 | 823.08 | 678.15 | Upgrade
|
| Selling, General & Admin | 500.73 | 539.33 | 507.35 | 584.99 | 782.43 | 569.59 | Upgrade
|
| Research & Development | 39.35 | 41.05 | 43.3 | 46.09 | 48.43 | 59.35 | Upgrade
|
| Amortization of Goodwill & Intangibles | 94.06 | 94.06 | 94.06 | 94.06 | 94.06 | 94.06 | Upgrade
|
| Operating Expenses | 634.13 | 674.43 | 644.7 | 725.14 | 924.91 | 722.99 | Upgrade
|
| Operating Income | -39.81 | -6.15 | -68.99 | -281.14 | -101.83 | -44.85 | Upgrade
|
| Interest Expense | -75.4 | -72.87 | -69.47 | -57.07 | -33.51 | -32.97 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.69 | 0.83 | 0.04 | 0.12 | 0.67 | 0.36 | Upgrade
|
| EBT Excluding Unusual Items | -113.52 | -78.18 | -138.43 | -338.09 | -134.67 | -77.46 | Upgrade
|
| Merger & Restructuring Charges | -6.2 | -0.9 | -2.69 | -37.53 | - | - | Upgrade
|
| Impairment of Goodwill | - | - | - | - | -386.55 | - | Upgrade
|
| Asset Writedown | -254.66 | - | -10 | - | -1.06 | - | Upgrade
|
| Other Unusual Items | -4.69 | 74.03 | - | - | -11.94 | -19.7 | Upgrade
|
| Pretax Income | -379.07 | -5.05 | -151.12 | -375.62 | -534.22 | -97.16 | Upgrade
|
| Income Tax Expense | 2.65 | 2.27 | 0.15 | 0.76 | -0.02 | 0.04 | Upgrade
|
| Earnings From Continuing Operations | -381.72 | -7.32 | -151.27 | -376.38 | -534.19 | -97.2 | Upgrade
|
| Minority Interest in Earnings | 182.7 | 4.39 | 88.01 | 227.68 | 344.84 | 52.93 | Upgrade
|
| Net Income | -199.02 | -2.93 | -63.26 | -148.71 | -189.36 | -44.27 | Upgrade
|
| Preferred Dividends & Other Adjustments | 3.86 | 3.66 | 3.57 | 0.94 | - | -25.47 | Upgrade
|
| Net Income to Common | -202.88 | -6.59 | -66.82 | -149.65 | -189.36 | -18.8 | Upgrade
|
| Shares Outstanding (Basic) | 11 | 10 | 9 | 8 | 7 | 6 | Upgrade
|
| Shares Outstanding (Diluted) | 11 | 10 | 9 | 8 | 7 | 6 | Upgrade
|
| Shares Change (YoY) | 16.40% | 7.40% | 10.03% | 19.52% | 25.91% | -95.24% | Upgrade
|
| EPS (Basic) | -17.72 | -0.66 | -7.19 | -17.72 | -26.80 | -3.35 | Upgrade
|
| EPS (Diluted) | -17.72 | -0.66 | -7.19 | -17.72 | -26.80 | -3.35 | Upgrade
|
| Free Cash Flow | -78.74 | -35.34 | 95.41 | 47.39 | -318.81 | -128.74 | Upgrade
|
| Free Cash Flow Per Share | -6.88 | -3.54 | 10.27 | 5.61 | -45.12 | -22.94 | Upgrade
|
| Gross Margin | 80.50% | 83.65% | 78.36% | 70.29% | 77.47% | 77.30% | Upgrade
|
| Operating Margin | -5.39% | -0.77% | -9.39% | -44.51% | -9.59% | -5.11% | Upgrade
|
| Profit Margin | -27.48% | -0.83% | -9.10% | -23.69% | -17.82% | -2.14% | Upgrade
|
| Free Cash Flow Margin | -10.66% | -4.42% | 12.99% | 7.50% | -30.01% | -14.67% | Upgrade
|
| EBITDA | 58.72 | 91.64 | 28.95 | -180.64 | 1.48 | 52.11 | Upgrade
|
| EBITDA Margin | 7.95% | 11.47% | 3.94% | -28.60% | 0.14% | 5.94% | Upgrade
|
| D&A For EBITDA | 98.52 | 97.79 | 97.95 | 100.5 | 103.31 | 96.95 | Upgrade
|
| EBIT | -39.81 | -6.15 | -68.99 | -281.14 | -101.83 | -44.85 | Upgrade
|
| EBIT Margin | -5.39% | -0.77% | -9.39% | -44.51% | -9.59% | -5.11% | Upgrade
|
| Revenue as Reported | - | - | - | - | - | 877.35 | Upgrade
|
| Advertising Expenses | - | 201.7 | 188.3 | 178.7 | 323.3 | 156.9 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.